Associate Professor @UZH_en@Unispital_USZ@CCCZ_USZ studying the pathogenesis of cancer with a particular focus on TP53-mutant myeloid (pre-)malignancies
Excited to share our latest work. Applying advanced single-molecule and single-cell DNA sequencing methods, we uncover an extraordinary landscape of somatic mutations in immune checkpoint genes in autoimmune lymphocytes. [1/n] rdcu.be/fdqbr
Ercc6l2 deficiency leads to replication stress, p53 pathway activation, and decreased Runx1 and Gata1 expression resulting in BMF. Read the plenary paper in Blood: ow.ly/nZ5l50YGL8b#plenarypaper#bloodjournal#p53
1/🔥 New paper from our lab!
#TP53-mutant clonal hematopoiesis (#CH) greatly increases risk for therapy-related #AML/MDS - but why?
We set out to dissect how mono- vs. biallelic #TP53 mutations drive leukemic evolution. nature.com/articles/s41375-0…
8/🍾🎉 Congratulations to #JonasFullin and the entire team, and many thanks to all collaborators!
đź“„ Read the full paper here:
“The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis” nature.com/articles/s41375-0…